This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach, Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy, April 2016, Elsevier,
DOI: 10.1016/j.saa.2016.01.049.
You can read the full text:
The following have contributed to this page
